Biophysical Society 59th Annual Meeting Program Guide

Author Disclosures

Authors of submitted abstracts completed a disclosure statement. Disclosures included any relationships that may bias one’s presentation or which, if known, could give the perception of bias. These situations include but are not limited to: 1. Stock options or bond holdings in a for-profit corporation or self-directed pension plan 2. Research funded by industry grant 3. Employment (full- or part-time) in funding company 4. Ownership or Partnership in funding organization 5. Consulting fees or other remuneration from industry 6. Non-remunerative positions of influence such as officer, board member, trustee, or public spokesperson in company 7. Receipt of royalties from referenced company products 8. Speaker’s bureau 9. Other Below is the list of authors and disclosures for programmed abstracts.

Name

Disclosure Entity

Disclosure Type

Presentation Number

Aldeghi, Matteo Alvaro, Giuseppe Amuzescu, Bogdan

Evotec (U.K.) Ltd.

Research funded by industry grant

1791-Plat

Autifony Therapeutics Limited Employment (full or part-time) in funding company 635-Pos Cytocentrics Bioscience GmbH Employment (full or part-time) in funding company 2954-Pos

Anantharaman, Thomas Andrzejewska, Weronika

BioNano Genomics

Employment (full or part-time) in funding company 742-Pos

grant (UMO-2011/01/B/ ST5/00846) fromNational Science Centre

Other

1972-Pos

Anson, Blake

CDI CDI

Employment (full or part-time) in funding company 3014-Pos Employment (full or part-time) in funding company 3014-Pos Employment (full or part-time) in funding company 2955-Pos

Aoyama, Natsuyo Armstrong, Luke Baddeley, David

ChanTest

Zeiss

Receipt of royalties from referenced company products

2393-Pos

Barker, John Bayley, Hagan

Evotec (U.K.) Ltd.

Employment (full or part-time) in funding company 1791-Plat

Oxford Nanopore Technologies Non-remunerative positions of influence such as officer, board member, trustee, or public spokesper- son in company

935-Plat

Beattie, Kylie

GlaxoSmithKline Gilead Sciences

Research funded by industry grant

605-Pos

Belardinelli, Luiz

Employment (full or part-time) in funding company 1395-Pos

Benjamin, Christopher

Pandion Laboratories LLC Research funded by industry grant

3115-Pos 1985-Pos

Benner, Steven

Firebird Molecular Sciences

Receipt of royalties from referenced company products

Berne, Bruce Bers, Donald Bett, Glenna Bett, Glenna Bett, Glenna

Schrodinger Inc Gilead Sciences Cytocybernetics Cytocybernetics Cytocybernetics

Consulting fees or other remuneration from industry 60-Plat

Research funded by industry grant

981-Plat

Ownership or Partnership in funding organization 560-Pos Ownership or Partnership in funding organization 561-Pos Ownership or Partnership in funding organization 1366-Pos Consulting fees or other remuneration from industry 2398-Pos

Bewersdorf, Joerg

Bruker Corporation

251

Biophysical Society 59 th Annual Meeting, Baltimore, Maryland